Yet another HDM2 antagonist which is evaluated in combination with cytarabine in acute myeloid leukemia or advanced myelodysplastic syndrome patients is stapled peptide ALRN-6924 (NCT02909972). Here, MDM2 is linked to acute myeloid leukemia.